P-230Effectiveness of CA 19.9 in predicting prognosis in metastatic pancreatic cancer patients treated with nab-paclitaxel plus gemcitabine. (2nd July 2019) - Mariani, S; Soro, P; Liscia, N; Balconi, F; Camera, S; Donisi, C; Impera, V; Musio, F; Persano, M; Pireddu, A; Pretta, A; Tolu, S; et al.